Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 176

1.

High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic.

Norton BL, Fleming J, Bachhuber MA, Steinman M, DeLuca J, Cunningham CO, Johnson N, Laraque F, Litwin AH.

Int J Drug Policy. 2017 Aug 12. pii: S0955-3959(17)30235-9. doi: 10.1016/j.drugpo.2017.07.021. [Epub ahead of print]

PMID:
28811158
2.

Late outcomes of gold weights and platinum chains for upper eyelid loading.

Siah WF, Nagendran S, Tan P, Ali Ahmad SM, Litwin AS, Malhotra R.

Br J Ophthalmol. 2017 Jul 8. pii: bjophthalmol-2016-310089. doi: 10.1136/bjophthalmol-2016-310089. [Epub ahead of print]

PMID:
28689170
3.

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

Grebely J, Bruneau J, Lazarus JV, Dalgard O, Bruggmann P, Treloar C, Hickman M, Hellard M, Roberts T, Crooks L, Midgard H, Larney S, Degenhardt L, Alho H, Byrne J, Dillon JF, Feld JJ, Foster G, Goldberg D, Lloyd AR, Reimer J, Robaeys G, Torrens M, Wright N, Maremmani I, Norton BL, Litwin AH, Dore GJ; International Network on Hepatitis in Substance Users.

Int J Drug Policy. 2017 Jul 3. pii: S0955-3959(17)30123-8. doi: 10.1016/j.drugpo.2017.05.019. [Epub ahead of print]

PMID:
28683982
4.

Effect of universal chlorhexidine decolonisation on the infection rate in intensive care patients.

Duszyńska W, Adamik B, Lentka-Bera K, Kulpa K, Nieckula-Schwarz A, Litwin A, Stróżecki Ł, Kübler A.

Anaesthesiol Intensive Ther. 2017;49(1):28-33. doi: 10.5603/AIT.2017.0007.

5.

Can We Improve the Tolerance of an Ocular Prosthesis by Enhancing Its Surface Finish?

Litwin AS, Worrell E, Roos JC, Edwards B, Malhotra R.

Ophthal Plast Reconstr Surg. 2017 Mar 7. doi: 10.1097/IOP.0000000000000891. [Epub ahead of print]

PMID:
28272105
6.

Retention in buprenorphine treatment is associated with improved HCV care outcomes.

Norton BL, Beitin A, Glenn M, DeLuca J, Litwin AH, Cunningham CO.

J Subst Abuse Treat. 2017 Apr;75:38-42. doi: 10.1016/j.jsat.2017.01.015. Epub 2017 Jan 27.

PMID:
28237052
7.

Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C.

Grebely J, Swan T, Hickman M, Bruneau J, Bruggmann P, Dalgard O, Litwin A, Backmund M, Dore GJ; International Network for Hepatitis in Substance Users.

J Hepatol. 2017 May;66(5):1101-1103. doi: 10.1016/j.jhep.2016.12.028. Epub 2017 Feb 3. No abstract available.

8.

Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.

Akiyama MJ, Kaba F, Rosner Z, Alper H, Kopolow A, Litwin AH, Venters H, MacDonald R.

Public Health Rep. 2017 Jan/Feb;132(1):41-47. doi: 10.1177/0033354916679367. Epub 2016 Dec 14.

PMID:
28005477
9.

Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.

Dore GJ, Altice F, Litwin AH, Dalgard O, Gane EJ, Shibolet O, Luetkemeyer A, Nahass R, Peng CY, Conway B, Grebely J, Howe AY, Gendrano IN, Chen E, Huang HC, Dutko FJ, Nickle DC, Nguyen BY, Wahl J, Barr E, Robertson MN, Platt HL; C-EDGE CO-STAR Study Group.

Ann Intern Med. 2016 Nov 1;165(9):625-634. doi: 10.7326/M16-0816. Epub 2016 Aug 9.

PMID:
27537841
10.

How can we maximize the use of our operating lists? An analysis of factors influencing theatre efficiency in oculoplastic day surgery.

Nagendran ST, Siah WF, Litwin A, Barbosa C, Jayatilake J, Malhotra R.

Orbit. 2016 Dec;35(6):309-312. Epub 2016 Sep 12.

PMID:
27617351
11.

Cigarette Smoking Behaviors and Beliefs in Persons Living With Hepatitis C.

Shuter J, Litwin AH, Sulkowski MS, Feinstein A, Bursky-Tammam A, Maslak S, Weinberger AH, Esan H, Segal KS, Norton B.

Nicotine Tob Res. 2017 Jul 1;19(7):836-844. doi: 10.1093/ntr/ntw212.

PMID:
27613890
12.

Effect of Manuka Honey on Eyelid Wound Healing: A Randomized Controlled Trial.

Malhotra R, Ziahosseini K, Poitelea C, Litwin A, Sagili S.

Ophthal Plast Reconstr Surg. 2017 Jul/Aug;33(4):268-272. doi: 10.1097/IOP.0000000000000743.

PMID:
27429228
13.

Addressing reimbursement disparities for direct-acting antiviral therapies for hepatitis C virus infection is essential to ensure access for all.

Grebely J, Litwin A, Dore GJ.

J Viral Hepat. 2016 Sep;23(9):664-6. doi: 10.1111/jvh.12550. Epub 2016 Jun 8. No abstract available.

PMID:
27272285
14.

Periorbital Autologous Fat Grafting in Facial Nerve Palsy.

Siah WF, Litwin AS, Nduka C, Malhotra R.

Ophthal Plast Reconstr Surg. 2017 May/Jun;33(3):202-208. doi: 10.1097/IOP.0000000000000710.

PMID:
27144439
15.

No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening.

Norton BL, Southern WN, Steinman M, Smith BD, Deluca J, Rosner Z, Litwin AH.

Clin Gastroenterol Hepatol. 2016 Sep;14(9):1356-60. doi: 10.1016/j.cgh.2016.04.017. Epub 2016 Apr 19.

PMID:
27108792
16.

Urinary tract infections in intensive care unit patients - a single-centre, 3-year observational study according to the INICC project.

Duszyńska W, Rosenthal VD, Szczęsny A, Woźnica E, Ulfik K, Ostrowska E, Litwin A, Kübler A.

Anaesthesiol Intensive Ther. 2016;48(1):1-6. doi: 10.5603/AIT.2016.0001.

17.

Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection.

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; l’International Network on Hepatitis among Substance Users (Réseau international sur l’hépatite chez les consommateurs de drogues).

Int J Drug Policy. 2015 Nov 28. pii: S0955-3959(15)00351-5. doi: 10.1016/j.drugpo.2015.11.009. [Epub ahead of print] No abstract available.

PMID:
26847504
18.

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden.

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; im Namen vom International Network on Hepatitis care in Substance Users.

Int J Drug Policy. 2015 Nov 28. pii: S0955-3959(15)00352-7. doi: 10.1016/j.drugpo.2015.11.010. [Epub ahead of print] German. No abstract available.

PMID:
26749563
19.

A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study.

Southern WN, Norton B, Steinman M, DeLuca J, Drainoni ML, Smith BD, Litwin AH.

BMC Infect Dis. 2015 Dec 1;15:553. doi: 10.1186/s12879-015-1283-3.

20.

CADS grading scale: towards better grading of ophthalmic involvement in facial nerve paralysis.

Malhotra R, Ziahosseini K, Litwin A, Nduka C, El-Shammah N.

Br J Ophthalmol. 2016 Jun;100(6):866-70. doi: 10.1136/bjophthalmol-2015-307167. Epub 2015 Oct 15.

PMID:
26472405

Supplemental Content

Loading ...
Support Center